Dr Patrick Lloyd Scarborough, MD | |
200 Mercy Circle, Camp Pendleton, CA 92055 | |
(801) 380-4986 | |
Not Available |
Full Name | Dr Patrick Lloyd Scarborough |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 13 Years |
Location | 200 Mercy Circle, Camp Pendleton, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497040513 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | A122225 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Enloe Medical Center | Chico, CA | Hospital |
Oroville Hospital | Oroville, CA | Hospital |
Adventist Health Clearlake | Clearlake, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Enloe Medical Center | 9739092388 | 287 |
News Archive
For the third consecutive year, a grant for $25,000 from The Prem Rawat Foundation (TPRF) will help St John of Jerusalem Eye Hospital (SJJEH) provide eye care to children in East Jerusalem, the West Bank and Gaza.
An international research team has built molecular "clamps" out of DNA that offer a powerful new tool for identifying individuals with an increased risk of cancer.
After the campus shootings at Virginia Tech in 2007 and Northern Illinois University in 2008, hundreds of affected students turned to social media websites to share their grief and search for solace. A new study of these students found that their online activities neither helped nor harmed their long-term psychological health.
Innate Immune, Inc., a privately held biotechnology company, today announced that it has granted to Cephalon Australia Pty Ltd an exclusive license to patents for the development of its antibodies for the treatment of asthma and systemic lupus erythematosis (SLE).
› Verified 8 days ago
Entity Name | Enloe Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396753281 PECOS PAC ID: 9739092388 Enrollment ID: O20031110000404 |
News Archive
For the third consecutive year, a grant for $25,000 from The Prem Rawat Foundation (TPRF) will help St John of Jerusalem Eye Hospital (SJJEH) provide eye care to children in East Jerusalem, the West Bank and Gaza.
An international research team has built molecular "clamps" out of DNA that offer a powerful new tool for identifying individuals with an increased risk of cancer.
After the campus shootings at Virginia Tech in 2007 and Northern Illinois University in 2008, hundreds of affected students turned to social media websites to share their grief and search for solace. A new study of these students found that their online activities neither helped nor harmed their long-term psychological health.
Innate Immune, Inc., a privately held biotechnology company, today announced that it has granted to Cephalon Australia Pty Ltd an exclusive license to patents for the development of its antibodies for the treatment of asthma and systemic lupus erythematosis (SLE).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Patrick Lloyd Scarborough, MD 2159 Island Shore Way, San Marcos, CA 92078-5482 Ph: (801) 380-4986 | Dr Patrick Lloyd Scarborough, MD 200 Mercy Circle, Camp Pendleton, CA 92055 Ph: (801) 380-4986 |
News Archive
For the third consecutive year, a grant for $25,000 from The Prem Rawat Foundation (TPRF) will help St John of Jerusalem Eye Hospital (SJJEH) provide eye care to children in East Jerusalem, the West Bank and Gaza.
An international research team has built molecular "clamps" out of DNA that offer a powerful new tool for identifying individuals with an increased risk of cancer.
After the campus shootings at Virginia Tech in 2007 and Northern Illinois University in 2008, hundreds of affected students turned to social media websites to share their grief and search for solace. A new study of these students found that their online activities neither helped nor harmed their long-term psychological health.
Innate Immune, Inc., a privately held biotechnology company, today announced that it has granted to Cephalon Australia Pty Ltd an exclusive license to patents for the development of its antibodies for the treatment of asthma and systemic lupus erythematosis (SLE).
› Verified 8 days ago